Skip to main content
Equibles

STEPHENS INC /AR/

Position in LGND — Ligand Pharmaceuticals Inc

CIK 757657 LITTLE ROCK, AR
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$513,646
+$189,215 QoQ
Shares Held
1,625
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#247
of 414 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEPHENS INC /AR/ holds $5,988,068 across 12 Biotechnology names. LGND ranks #5 (8.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,900 $1,440,517
2 TECH
BIO-TECHNE Corp
 12,036 $850,343
3 TWST
Twist Bioscience Corp
 5,167 $531,580
4 REGN
Regeneron Pharmaceuticals, Inc.
 831 $518,161
5 LGND
Ligand Pharmaceuticals Inc
This page 		1,625 $513,646
6 EXEL
Exelixis, Inc.
 9,079 $493,988
7 ALNY
Alnylam Pharmaceuticals, Inc.
 1,638 $493,087
8 HALO
Halozyme Therapeutics, Inc.
 4,954 $387,749

All Filings in LGND

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $513,646 1,625
2026-03-31 $324,431 1,625
2025-12-31 $313,099 1,656
2025-09-30 $294,052 1,660
2024-03-31 $79,971 1,094
2023-12-31 $78,133 1,094
2023-09-30 $68,788 1,148
2023-06-30 $126,030 1,748
2023-03-31 $131,525 1,788
2022-12-31 $119,104 1,783
2022-09-30 $153,534 1,783
2022-06-30 $163,361 1,831
2022-03-31 $212,156 1,886
2021-12-31 $327,455 2,120
2021-09-30 $284,212 2,040
2021-06-30 $255,164 1,945
2021-03-31 $290,569 1,906
2020-12-31 $359,511 3,615
2020-09-30 $324,469 3,404
2020-06-30 $369,887 3,307
2020-03-31 $1,821,052 25,042